Iconovo AB
- Medical device or technology
- Biotech or pharma, therapeutic R&D
ICONOVO develops Dry Powder Inhalers (DPI) and tailored formulations for drug delivery to lungs and/or nasal cavities.
Optimal administration for i.e. pulmonary/respiratory , vaccines, CNS, cancer, immunologic, obesity and metabolic indications